Literature DB >> 10543925

Cardiac myocyte apoptosis.

S A Cook1, P A Poole-Wilson.   

Abstract

Mesh：

Year:  1999        PMID： 10543925     DOI： 10.1053/euhj.1999.1548

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  10 in total

1.  Effect of ginsenoside Re on cardiomyocyte apoptosis and expression of Bcl-2/Bax gene after ischemia and reperfusion in rats.

Authors:  Zhengxiang Liu; Zhigang Li; Xiaochun Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

Review 2.  Cardiomyocyte Proliferation from Fetal- to Adult- and from Normal- to Hypertrophy and Failing Hearts.

Authors:  Sanford P Bishop; Jianyi Zhang; Lei Ye
Journal:  Biology (Basel)       Date:  2022-06-08

3.  Cardiac protein changes in ischaemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue.

Authors:  Esther Roselló-Lletí; Jana Alonso; Raquel Cortés; Luis Almenar; Luis Martínez-Dolz; Ignacio Sánchez-Lázaro; Francisca Lago; Inmaculada Azorín; Jose R González Juanatey; Manuel Portolés; Miguel Rivera
Journal:  J Cell Mol Med       Date:  2012-10       Impact factor: 5.310

4.  Antiapoptotic actions of methyl gallate on neonatal rat cardiac myocytes exposed to H2O2.

Authors:  Sandhya Khurana; Amanda Hollingsworth; Matthew Piche; Krishnan Venkataraman; Aseem Kumar; Gregory M Ross; T C Tai
Journal:  Oxid Med Cell Longev       Date:  2014-01-12       Impact factor: 6.543

5.  Aberrant dynamin 2-dependent Na(+) /H(+) exchanger-1 trafficking contributes to cardiomyocyte apoptosis.

Authors:  Jun Li; Liang Xu; Jiangchuan Ye; Xiang Li; Dasheng Zhang; Dandan Liang; Xinran Xu; Man Qi; Changming Li; Hong Zhang; Jing Wang; Yi Liu; Yuzhen Zhang; Zhaonian Zhou; Xingqun Liang; Jue Li; Luying Peng; Weidong Zhu; Yi-Han Chen
Journal:  J Cell Mol Med       Date:  2013-07-09       Impact factor: 5.310

6.  Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension.

Authors:  Daniel N Meijles; Joshua J Cull; Thomais Markou; Susanna T E Cooper; Zoe H R Haines; Stephen J Fuller; Peter O'Gara; Mary N Sheppard; Sian E Harding; Peter H Sugden; Angela Clerk
Journal:  Hypertension       Date:  2020-09-09       Impact factor: 10.190

7.  Conductive nanocomposite hydrogel and mesenchymal stem cells for the treatment of myocardial infarction and non-invasive monitoring via PET/CT.

Authors:  Ke Zhu; Dawei Jiang; Kun Wang; Danzha Zheng; Ziyang Zhu; Fuqiang Shao; Ruijie Qian; Xiaoli Lan; Chunxia Qin
Journal:  J Nanobiotechnology       Date:  2022-05-06       Impact factor: 9.429

8.  MMP-2 and sTNF-R1 Variability in Patients with Essential Hypertension: 1-Year Follow-Up Study.

Authors:  Núria Carpena; Esther Roselló-Lletí; Jose R Calabuig; Estefanía Tarazón; Jose R González-Juanatey; Luis Martínez-Dolz; Antonio Salvador; Lilian Grigorian; Plácido Orosa; Manuel Portolés; Miguel Rivera
Journal:  ISRN Cardiol       Date:  2012-09-13

9.  The ral exchange factor rgl2 promotes cardiomyocyte survival and inhibits cardiac fibrosis.

Authors:  Rebecca L Scotland; Leah Allen; Leah J Hennings; Ginell R Post; Steven R Post
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

Review 10.  Insights Into Genetics and Pathophysiology of Arrhythmogenic Cardiomyopathy.

Authors:  Brenda Gerull; Andreas Brodehl
Journal:  Curr Heart Fail Rep       Date:  2021-09-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.